Transparency: Voluntary Disclosure of Payments to Healthcare Professionals and Healthcare Organizations
The Voluntary Framework on Disclosure was developed by Innovative Medicines Canada. As a partner in Canada’s healthcare system, Novartis Pharmaceuticals Canada Inc. (Novartis) regularly collaborates with healthcare professionals (HCPs) and healthcare organizations (HCOs) to foster scientific exchange, for the ultimate benefit of patients. These collaborations are bound by local and international laws and regulated by Innovative Medicines Canada’s Code of Ethical Practices. Novartis’ decision to publish our payments to HCPs and HCOs is voluntary and part of our overall commitment to greater transparency and high ethical standards in our business practices.
Novartis is proud of the relationships we have with Canadian HCPs, HCOs and other healthcare stakeholders. These relationships are critical to advancing scientific knowledge, education and quality of care for patients. By bringing greater transparency to our work, we hope to foster stronger understanding of our industry’s collaborations across the healthcare sector, and enhance trust in Canada’s healthcare system.
Payment information from July 1, 2016 to December 31, 2016, has been captured in aggregate form (one sum total) and presented below in three categories:
Note: While the Company makes every effort to present accurate and reliable information, the Company makes no warranty and assumes no legal liability or responsibility for the accuracy or completeness of the information contained herein. The Company shall not be liable for damages resulting from the use or misuse of the information contained on this website. Certain links may lead to resources located on servers that are not maintained by Company or under its control, and such hypertext links are provided as a convenience only. The inclusion of a link does not imply endorsement by or of the referenced site and the Company is not responsible for the contents of or the availability of access to such websites.
*For clarity purposes only, please note the following:
Applicable taxes may be excluded.
The values provided may include certain related incidental expenses (such as, but not limited to reimbursement of mileage for travel).
Transfer of Value (ToV) is captured according to the payment date and not necessarily the date on which the activity occurred. Therefore, some activities in 2015 are reported as ToVs in 2016, and some activities that occurred in 2016 will be reported in the 2017 report.
Programs that have been discontinued in category 1 may not be captured.